• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma


38.5500 USD 0.8500 2.16%

As of 20:10:00 ET on 10/23/2014.

Snapshot for Eisai Co Ltd (ESALY)

Open: 38.8900 Day's Range: 38.5500 - 38.8900 Volume: 4,665
Previous Close: 39.4000 52wk Range: 36.5500 - 43.0300 1-Yr Rtn: -0.64%

Stock Chart for ESALY

No chart data available.
  • ESALY:US 38.5500
  • 1D
  • 1M
  • 1Y
Interactive ESALY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ESALY

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 33.8865
Relative P/E vs. SPX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 123.0680
Est. PEG Ratio 3.7485
Market Cap (M USD) 11,432.66
Shares Outstanding (M) 296.57
30 Day Average Volume 7,488
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.08%
Cash Dividend (USD) -
Dividend Ex-Date 09/25/2014
5 Year Dividend Growth -12.99%
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ESALY

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for ESALY

Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.

Hideaki MatsuiDirectorNobuo DeguchiDirector
Noboru NaoeDirectorHaruo NaitoRep Corporate Officer/CEO
More Company Profile & Key Executives for ESALY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil